脂肪酶来源于洋葱假单胞菌，Lipase from Pseudomonas cepacia；powder, light beige, ≥30 U/mg
最近浏览商品
-
盐酸二甲双胍，Metformin hydrochloride；97% -
![图片 脂肪酶来源于猪胰腺 [PPL]，Lipase from porcine pancreas；Type II, ≥125 units/mg protein (using olive oil (30 min incubation)), 30-90 units/mg protein (using triacetin)](https://www.bszh.cn/images/thumbs/default-image_32.png "显示明细 脂肪酶来源于猪胰腺 [PPL]，Lipase from porcine pancreas；Type II, ≥125 units/mg protein (using olive oil (30 min incubation)), 30-90 units/mg protein (using triacetin)")
脂肪酶来源于猪胰腺 [PPL]，Lipase from porcine pancreas；Type II, ≥125 units/mg protein (using olive oil (30 min incubation)), 30-90 units/mg protein (using triacetin) -
![图片 视黄醇 [维生素A]，Retinol；BioXtra, ≥97.5% (HPLC), ~3100 U/mg](https://www.bszh.cn/images/thumbs/0000980_-aretinolbioxtra-975-hplc-3100-umg_32.png "显示明细 视黄醇 [维生素A]，Retinol；BioXtra, ≥97.5% (HPLC), ~3100 U/mg")
视黄醇 [维生素A]，Retinol；BioXtra, ≥97.5% (HPLC), ~3100 U/mg -
L-谷氨酰胺，L-Glutamine；≥99% -
![图片 聚(乙二醇)甲基丙烯酸酯，Poly(ethylene glycol) methacrylate [PEGMA]；average Mn 360, contains 500-800 ppm MEHQ as inhibitor](https://www.bszh.cn/images/thumbs/0007154_polyethylene-glycol-methacrylate-pegmaaverage-mn-360-contains-500-800-ppm-mehq-as-inhibitor_32.png "显示明细 聚(乙二醇)甲基丙烯酸酯，Poly(ethylene glycol) methacrylate [PEGMA]；average Mn 360, contains 500-800 ppm MEHQ as inhibitor")
聚(乙二醇)甲基丙烯酸酯，Poly(ethylene glycol) methacrylate [PEGMA]；average Mn 360, contains 500-800 ppm MEHQ as inhibitor -
![图片 胆酸钠水合物 [水合胆酸钠]，Sodium cholate hydrate；PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production.](https://www.bszh.cn/images/thumbs/0001858_-sodium-cholate-hydratepharmagrade-manufactured-under-appropriate-controls-for-use-as-a-raw-material_32.png "显示明细 胆酸钠水合物 [水合胆酸钠]，Sodium cholate hydrate；PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production.")
胆酸钠水合物 [水合胆酸钠]，Sodium cholate hydrate；PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production.
